Regeneron Pharmaceuticals Inc Provisional
FDA Flags (3)
Class II RecallAug 2026
Regeneron Pharmaceuticals Inc
Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution, Single-Dose Vial,
Classification: Class II
Class II RecallJun 2024
Regeneron Pharmaceuticals Inc
EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled
Classification: Class II
Class II RecallMay 2024
Regeneron Pharmaceuticals Inc
EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactur
Classification: Class II